Rocket Lab is described as a 'good short crap' despite trading over $100, indicating a bearish outlook.
Source Post
6/30/26 +0.93%
Martin ShkreliJun 30, 2026
The creator discusses various topics including technology, the human spirit, and personal hustle. He mentions Nvidia as a hardware company and highlights Asana Sciences as a generational opportunity. A significant portion of the content is dedicated to a critique of the FDA's stance on BPC 157, a peptide, arguing against its approval due to lack of evidence and questionable research origins.
Linked Mentions
Tickers discussed in this post
AbbVie is mentioned trading at $134.50 and later $135, with a note about a good safety update regarding concerns about its drug causing cancer.
AMD's trading volume of $9 billion, representing 10% of its market cap, is considered unusual.
SanDisk's trading volume of $12 billion, exceeding Nvidia's, is noted as highly unusual.
Micron's significant trading volume of $22 billion is highlighted as unusual.
The creator uses Facebook's post-IPO performance as an example of a stock that initially struggled but eventually saw significant growth.
The creator recalls the Google IPO in 2004, noting its unique Dutch auction process and the company's early valuation discussions.
Abbyax has seen a huge return and is now at a $10 billion market cap, potentially reaching 5-10 billion in peak sales, but the upside is less relevant now and requires patience.
Nvidia is identified as a hardware company.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.